問題 › 次にどこに投資すべきか › B2B SaaS
資金配分が誤るのは、最も声の大きい部門に資金が回る場合であり、次の1ドルで最も高いリターンを生む部門ではない場合です。 B2B SaaS企業の場合、この問題は特定の形で現れます。答えを担う数字は純収益維持率とCAC paybackであり、この業界特有の複雑さは、成長率が42%から32%に低下している一方で、収益の60%が最も経済性の悪いセグメントに集中している点です。一般的な問題と実際に直面している問題では、最初の動きが異なります。
資金配分が誤るのは、最も声の大きい部門に資金が回る場合であり、次の1ドルで最も高いリターンを生む部門ではない場合です。 B2B SaaS企業の場合、この問題は特定の形で現れます。答えを担う数字は純収益維持率とCAC paybackであり、この業界特有の複雑さは、成長率が42%から32%に低下している一方で、収益の60%が最も経済性の悪いセグメントに集中している点です。一般的な問題と実際に直面している問題では、最初の動きが異なります。
多くの企業は過去の実績と主張の強さで配分を決めます。前年に資金を得た部門がまた得て、議論が上手い人が増分を手にします。どちらも、次の1ドルが最も多く稼ぐ場所とは関係がありません。
有効な分析は、各部門を二つの基準で並べます。増分投資に対するリターンと、そのリターンが持続する期間です。短期で高いリターンを生むが十八ヶ月で減衰する部門と、控えめながら十年続く部門は別物です。これらを同等に扱うと、衰退に資金を回すことになります。
出力は予算の分割ではなく、順序と停止条件です。どれを最初に実行し、次に何に資金を振り向け、どの観測値が出たら順序を誤りと判断するか。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 予算は前年実績に一定割合を加えて決定される
✓ 増分投資に対するリターン順に部門を並べられる人がいない
✓ 投資判断が算術ではなく戦略的重要性で正当化される
通常、事態を悪化させる対応です。 平和を保つために資本を均等に分散させ、複利効果を発揮するはずのものを過小に資金投入してしまうことです。
It is for you if you run or finance a B2B SaaS company and budgets are set by last year plus a percentage. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on B2B SaaS企業. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Customer Value Architecture · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For B2B SaaS企業 it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
持続性を明示的に評価します。減衰するリターンには半減期を明記します。各選択肢に半減期を付与すれば、異なる時間軸の選択肢を比較可能になります。
通常は最も強い部分です。限界的な1ドルが複利を生むのはそこだからです。弱い部分を直す価値があるのは、それが強い部分の制約になっている場合に限ります。
可逆性で決めます。リターンが近い場合、途中で止められる方を選びます。得られる情報の価値が推定値の差を上回るからです。
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית